220 results on '"Stine, Kimo"'
Search Results
2. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
3. MicroRNA‐34a‐5p as a promising early circulating preclinical biomarker of doxorubicin‐induced chronic cardiotoxicity
4. Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults with Severe Hemophilia a
5. Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study
6. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
7. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
8. Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice
9. Doxorubicin‐induced delayed‐onset subclinical cardiotoxicity in mice.
10. A Novel Germline TP53 Mutation in a Patient With Li-Fraumeni Syndrome: Resolving a Variant of Uncertain Significance
11. A patient with hyperuricemia and renal failure:answer
12. Updated Follow-up of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (SB-525) Gene Therapy in Adults with Severe Hemophilia a
13. A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A
14. Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia
15. A NOVEL GERMLINE TP53 MUTATION IN A PATIENT WITH LI-FRAUMENI SYNDROME - RESOLVING A VARIANT OF UNCERTAIN SIGNIFICANCE
16. Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patients with Severe Hemophilia A
17. Reconversion of bone marrow in Gaucher disease treated with enzyme therapy documented by MR
18. Treatment of Deep Vein Thrombosis With Enoxaparin in Pediatric Cancer Patients Receiving Chemotherapy
19. House Officer Survey of Hematologists To Determine Personal/Institutional Preferences Regarding Management of Hemophilia Patients During Surgical Interventions: 315
20. Intensive Therapy With Growth Factor Support for Patients With Ewing Tumor Metastatic at Diagnosis: Pediatric Oncology Group/Childrenʼs Cancer Group Phase II Study 9457—A Report From the Childrenʼs Oncology Group
21. Venorelbine and Methotrexate for the Treatment of Rosai-Dorfman Disease: Response
22. Cyclophosphamide Plus Topotecan in Children With Recurrent or Refractory Solid Tumors: A Pediatric Oncology Group Phase II Study
23. Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: The hemorrhagic lupus anticoagulant syndrome
24. Impact of Dietary Yogurt on Immune Function
25. Telomere fusion as a mechanism for the progressive loss of the short arm of chromosome 11 in an anaplastic Wilms' tumor
26. KRN5500 induces apoptosis (PCD) of myeloid leukemia cell lines and patient blasts
27. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection
28. A Novel Germline TP53Mutation in a Patient With Li-Fraumeni Syndrome: Resolving a Variant of Uncertain Significance
29. The genomic landscape of juvenile myelomonocytic leukemia
30. Nutlin-3 treatment spares cisplatin-induced inhibition of bone healing while maintaining osteosarcoma toxicity
31. Correction: Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia
32. The genomic landscape of juvenile myelomonocytic leukemia
33. Risk organ + LCH gets the one-two punch?
34. Dissecting the Heterogeneity of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis
35. Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)
36. Dissecting the heterogeneity of macrophage activation syndrome
37. von Willebrand Factor Multimers in Pediatric Extracorporeal Membrane Oxygenation Support
38. Cellular anti-GP120 cytolytic reactivities in HIV-1 seropositive individuals
39. Cisplatin inhibits bone healing during distraction osteogenesis
40. A Pilot Study To Examine The Effect Of Extracorporeal Membrane Oxygenation (ECMO) On Plasma Factor XIII Levels
41. Response to steroids predicts response to rituximab in pediatric chronic immune thrombocytopenia
42. The North American Chronic Immune Thrombocytopenia Registry (NACIR): Demographics and Treatment Responses
43. Response to Steroids Predicts Response to Rituximab In Pediatric Chronic Immune Thrombocytopenia.
44. C-Reactive Protein and Soluble IL-2Receptor Correlate with High Risk of Clinical Sepsis Among Children with Fever and Neutropenia.
45. Phase II Study of Clofarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
46. Effects of Angiotensin-Converting Enzyme Inhibition on Thromboelastogaphy for Infants and Children Presenting for Elective Cardiac Surgery.
47. Cardiomyopathy in Children With Down Syndrome Treated for Acute Myeloid Leukemia: A Report From the Children's Oncology Group Study POG 9421
48. Use of FEIBA for Invasive or Surgical Procedures in Patients With Severe Hemophilia A or B With Inhibitors
49. Long-term use of the thrombopoietin-mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP).
50. Major Surgical Interventions - Survey of Hematologists To Determine Personal/Institutional Preferences Regarding Management of Hemophilia Patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.